Skip to content
DataLookout
Menu

NCT07935252

Prolonged Multimodal Analgesia for Postsurgical Pain

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Incidence of moderate-to-severe chronic pain at 3 months postoperatively
Timeframe: postoperative 3 months

Arms and interventions

Prolonged Multimodal Analgesia GroupExperimental

Pre-operative (1 hour): pregabalin 150mg; Intraoperative: Esketamine 0.09 mg/kg/h pumping; Post-operative: Esketamine combined with dexmedetomidine PCA: the esketamine dosage is 0.06 mg/kg/h, dexmedetomidine dosage is 1.5 μg/kg, and the PCA pump is used for 48 hours; Pregabalin 75 mg bid in 1-7 days and Pregabalin 75 mg qd in 8-21days. The anesthesiologist may adjust the drug dosage as appropriate based on the patient's condition, and all medications administered must be documented in detail. drugs:Esketamine, dexmedetomidine, pregabalin device:Patient Controlled Analgesia(PCA)

Conventional Analgesia GroupActive comparator

The participant will be administrated by Sulfentanil PCA (1.5μg/kg) in postoperative 48h. The anesthesiologist may adjust the drug dosage as appropriate based on the patient's condition, and all medications administered must be documented in detail.

Drugs: Esketamine, dexmedetomidine, pregabalin, Sufentanil